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Knowledge of HIV status through HIV testing constitutes the
first step towards HIV treatment and prevention services. HIV
self-testing (HIVST), whereby individuals collect their own
specimen, conduct their own test and interpret the results,
allows individuals to learn their HIV status conveniently and
privately, as well as to decide when and where to attend post-
test services. Accurate estimation of the proportion of those
tested who link to additional HIV care, treatment and preven-
tion services is critical in quantifying the health impact of HIV
testing. As HIVST becomes integrated into testing pro-
grammes worldwide, implementers in diverse settings will
need to measure the effectiveness of their programmes to
ensure self-testers link to onward care and services. This can
be challenging, and community health programmes in many
contexts find it difficult to track referral uptake and equity [1].
We draw upon experience from the Self-Testing in AfRica
(STAR) Initiative in 2015 to 2017 to identify three lessons for
measurement of linkage following HIVST. In STAR, two prag-
matic cluster-randomized trials evaluated the effectiveness of
continuous HIVST distribution over 12 months in increasing
testing coverage and linkage to care in Malawi and Zambia. A
third trial, in Zimbabwe, evaluated the effectiveness of an
incentive to promote linkage following a short, campaign-style
HIVST distribution programme, and included a non-randomized
component assessing the association between HIVST distribu-
tion and antiretroviral therapy (ART) initiations in nearby clinics.
Details are provided elsewhere [2,3]. Each trial incorporated a
household survey and data collection from health facilities to
evaluate changes in HIV testing coverage and linkage to confir-
matory testing, care and prevention (Table 1).
LESSON 1. COLLECT USAGE
INFORMATION FROM USERS, NOT JUST
FROM DISTRIBUTORS AND CLINICS
User household surveys and qualitative research are typically
more time-consuming to collect than routine data from
distributors and clinics. However, this type of data is vital for
understanding how self-tests are being used. For example, in
Zimbabwe, 289 survey respondents reported a reactive
HIVST, of whom 216 (75%) were already on ART [2]. Forma-
tive qualitative work indicated that individuals already known
to be positive self-tested in trial communities to avoid inad-
vertent disclosure, to confirm their status or check for cure.
Without accounting for unintended use of HIVST by persons
already diagnosed and linked into HIV care, the number of
HIVSTs used by undiagnosed individuals will be overestimated,
and both linkage and cost-effectiveness measures are likely to
be overestimated.
LESSON 2. THE QUALITY OF LINKAGE
MEASURES USING CLINIC DATA
DEPEND NOT ONLY ON THE QUALITY
OF CLINIC DATA, BUT ALSO ON THE
SELF-TESTING DISTRIBUTION MODEL
AND LOCAL CONTEXT
In two STAR trials, we had contrasting findings about the effec-
tiveness of self-test distribution on increasing ART initiations at
local clinics, measured by routine clinic data. In Malawi, clinics in
areas with self-test distribution had a 14% increase in ART initi-
ations compared with clinics in areas without HIVST distribu-
tion (adjusted risk ratio (aRR) = 1.14; 95% CI: 0.75 to 1.75) [4],
but the wide confidence intervals suggest limited statistical evi-
dence for effectiveness. In contrast, the study in Zimbabwe
showed a somewhat larger increase in local ART initiations in
areas with HIVST distribution with stronger evidence for effec-
tiveness (aRR=1.27; 95% CI: 1.14 to 1.43) [5].
These studies used different designs, and the trial in Zim-
babwe had more clusters receiving HIVST distribution and more
power to detect differences. However, we believe these esti-
mates may also have been driven by the context and the dura-
tion of distribution. Universal test-and-treat interventions,
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including the HPTN 071 (PopART) and ANRS 12249 trials, have
found that linkage to care remains low even after substantial
efforts supporting testing and linkage. This suggests that it is
necessary to consider how contextual factors apart from the
availability of HIV testing services impact linkage to care [6,7].
The Zimbabwe study used a shorter, campaign approach to dis-
tributing HIVST and the implementing organization (Population
Services International) had initiatives facilitating linkage-to-care
across the study area. In contrast, distribution in Malawi was
continuous over 12 months, with linkage more diffuse across an
extended period. It is likely easier to detect increased linkage at
facilities if HIVST kits are distributed in short concentrated peri-
ods and in contexts where linkage after testing is relatively easy
for users. For programmes working in areas or in populations
where linkage is difficult, or for those distributing HIVST over an
extended period, alternative methods of measuring linkage may
provide more power to detect effects.
LESSON 3. MEASURE BOTH LINKAGE TO
TREATMENT AND TO PREVENTION
Increasing the availability and uptake of HIV prevention ser-
vices is increasingly recognized as necessary for reducing HIV
incidence rates [8]. As testing and treatment expand, the num-
ber of new diagnoses identified by testing programmes is
likely to decrease, and consequently, the denominators of link-
age-to-care measures will shrink. Expanding to include linkage-
to-prevention of persons not infected with HIV will increase
power to detect impacts of HIVST on population health.
In the STAR trials described above, linkage to prevention was
a consideration, but not the focus. For example, in Zambia, volun-
tary medical male circumcision (VMMC) mobilizers affiliated with
HIVST intervention clinics received HIVST kits to distribute to
clients. However, only four of the six intervention clinics had affil-
iated VMMC mobilizers and the proportion of test kits dis-
tributed within each area by VMMC mobilizers was low overall
(<1% to 11% across areas). There was a positive association
between the intervention and self-reported VMMC uptake, but
this was not statistically significant (aRR: 1.36; 95% CI: 0.49 to
3.78) [5]. With collaborators, STAR is now undertaking trials to
assess whether HIVST can be used to generate demand for pre-
vention services, including pre-exposure prophylaxis (PrEP)
among adolescent girls and young women in KwaZulu-Natal,
South Africa [9] and VMMC among men in urban Zimbabwe.
To summarize, defining and estimating linkage following
HIVST is complex, and there is no single measurement strategy
that will fit the needs of all HIVST implementers. Researchers
and implementers must account for contextual factors that may
affect users’ likelihood of linking and the amount of time
required to link when developing strategies to measure linkage
following HIVST. In STAR studies, it was difficult to anticipate
who would use HIVST, and where and when self-testers would
link to care. Where possible, collecting data on users’ self-test-
ing and linkage experiences can provide valuable insight.
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